These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9038732)

  • 121. P53 immunohistochemical expression: messages in cervical carcinogenesis.
    Cheah PL; Looi LM
    Pathology; 2002 Aug; 34(4):326-31. PubMed ID: 12190289
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Tissue expression of human epididymal secretory protein 4 may be useful in the differential diagnosis of uterine cervical tumors.
    Diniz G; Karadeniz T; Sayhan S; Akata T; Aydiner F; Ayaz D; Solakoglu Kahraman D; Akman T
    Ginekol Pol; 2017; 88(2):51-55. PubMed ID: 28326512
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 124. [Clinical significance of expression of enhancer of zeste homolog 2 and 53 in cervical squamous cell carcinoma and intraepithelial neoplasia].
    Zhang H; Chen S; Niu G; Jiang H; Yao S
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):597-601. PubMed ID: 25430026
    [TBL] [Abstract][Full Text] [Related]  

  • 125. The p53 tumour suppressor gene and tumour prognosis: is there a relationship?
    Dowell SP; Hall PA
    J Pathol; 1995 Nov; 177(3):221-4. PubMed ID: 8551382
    [No Abstract]   [Full Text] [Related]  

  • 126. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma.
    Oka K; Nakano T; Arai T
    Cancer; 1993 Jul; 72(1):160-4. PubMed ID: 8508400
    [TBL] [Abstract][Full Text] [Related]  

  • 127. p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix.
    Bosari S; Roncalli M; Viale G; Bossi P; Coggi G
    J Pathol; 1993 Apr; 169(4):425-30. PubMed ID: 8501539
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.
    Holm R; Skomedal H; Helland A; Kristensen G; Børresen AL; Nesland JM
    J Pathol; 1993 Jan; 169(1):21-6. PubMed ID: 8433212
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer.
    Bell SM; Scott N; Cross D; Sagar P; Lewis FA; Blair GE; Taylor GR; Dixon MF; Quirke P
    Gastroenterology; 1993 Jan; 104(1):57-64. PubMed ID: 8419262
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
    Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
    Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
    [TBL] [Abstract][Full Text] [Related]  

  • 131. p53 mutations in HPV-negative cervical carcinoma.
    Park DJ; Wilczynski SP; Paquette RL; Miller CW; Koeffler HP
    Oncogene; 1994 Jan; 9(1):205-10. PubMed ID: 8302581
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
    Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
    J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
    [TBL] [Abstract][Full Text] [Related]  

  • 133. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
    Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
    Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
    [TBL] [Abstract][Full Text] [Related]  

  • 134. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.
    Levine AJ; Perry ME; Chang A; Silver A; Dittmer D; Wu M; Welsh D
    Br J Cancer; 1994 Mar; 69(3):409-16. PubMed ID: 8123467
    [TBL] [Abstract][Full Text] [Related]  

  • 135. The role of p53 in tumor progression.
    Blondal JA; Benchimol S
    Semin Cancer Biol; 1994 Jun; 5(3):177-86. PubMed ID: 7948946
    [TBL] [Abstract][Full Text] [Related]  

  • 136. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms.
    Baas IO; Mulder JW; Offerhaus GJ; Vogelstein B; Hamilton SR
    J Pathol; 1994 Jan; 172(1):5-12. PubMed ID: 7931827
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Functional p53 protein in human papillomavirus-positive cancer cells.
    Butz K; Shahabeddin L; Geisen C; Spitkovsky D; Ullmann A; Hoppe-Seyler F
    Oncogene; 1995 Mar; 10(5):927-36. PubMed ID: 7898934
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.
    Park SY; Kang YS; Kim BG; Lee SH; Lee ED; Lee KH; Park KB; Lee JH
    Cancer Genet Cytogenet; 1995 Jan; 79(1):74-8. PubMed ID: 7850756
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The role of p53 inactivation in human cervical cell carcinoma development.
    Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
    Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Etiology of cervical cancer: current concepts.
    Bornstein J; Rahat MA; Abramovici H
    Obstet Gynecol Surv; 1995 Feb; 50(2):146-54. PubMed ID: 7731627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.